Manipulating Dose, Timing of Two Therapies Significantly Reduces Relapse in Mouse Models of Breast Cancer, Lung Cancer
August 09, 2019
August 09, 2019
DALLAS, Texas, Aug. 9 -- The University of Texas's Southwestern Medical Center issued the following news:
Changing the standard dose and timing of two therapies greatly cut tumor relapse and reduced side effects in mouse models of kinase mutated breast cancer and lung cancer, UT Southwestern Simmons Cancer Center researchers have found.
The study published today in Science Immunology suggests that giving the two therapies as short course, first-line treatment might work . . .
Changing the standard dose and timing of two therapies greatly cut tumor relapse and reduced side effects in mouse models of kinase mutated breast cancer and lung cancer, UT Southwestern Simmons Cancer Center researchers have found.
The study published today in Science Immunology suggests that giving the two therapies as short course, first-line treatment might work . . .